Phase III study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmenopausal women: analysis of survival and update of efficacy from the International Letrozole Breast Cancer Group - Mouridsen, H; Gershanovich, M; Sun, Y (J Clin Oncol, 2003)